A healthy investment in healthier futures.

Cryo-Cell has been a publicly traded company since 1991. Governed by the Securities & Exchange Commission, our common stock trades under the OTC QB: symbol CCEL. We specialize in stem cell preservation for family use.
 
 

Cryo-Cell Reports Financial Results for Fiscal 2015

OLDSMAR, Fla. – March 2, 2016 – Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year 2015.  
 
Financial Results
 
Revenue
 
Consolidated revenues for fiscal 2015 were approximately $21.1 million compared to approximately $20.1 million for fiscal 2014.  The revenues for fiscal 2015 consisted of approximately $19.6 million in processing and storage fee revenue, $1.0 million in licensee income, and $471,000 in product revenue compared to approximately $18.7 million in processing and storage fee revenue and approximately $1.5 million in licensee income for fiscal 2014.  

 

 

Read More


Cryo-Cell Reports Fiscal Third Quarter 2015 Results

OLDSMAR, Fla. – Oct. 16, 2015 – Cryo-Cell International, Inc. (the “Company”) (OTC:QB Markets Group Symbol: CCEL), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the second fiscal quarter ended August 31, 2015. 
 
Financial Results
 
Revenue

Consolidated revenues for the third quarter of fiscal 2015 were approximately $5.4 million compared to approximately $4.9 million for the third quarter of fiscal 2014.  The revenues for the third quarter of fiscal 2015 consisted of approximately $5.0 million in processing and storage fees, $169,000 in licensee income, and $260,000 in product revenue compared to approximately $4.8 million in processing and storage fees, $169,000 in licensee income and $0 in product revenue for the third quarter of fiscal 2014.

 

 
 

 

Read More


Cryo-Cell Reports Fiscal Second Quarter 2015 Financial Results

OLDSMAR, Fla. – July 16, 2015 Cryo-Cell International, Inc. (the “Company”) (OTC:QB Markets Group Symbol: CCEL), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the second fiscal quarter ended May 31, 2015. 
 
Financial Results
 
Revenue

Consolidated revenues for the second quarter of fiscal 2015 were approximately $5.0 million compared to approximately $4.9 million for the second quarter of fiscal 2014.  The revenues for the second quarter of fiscal 2015 consisted of approximately $4.8 million in processing and storage fee revenue and approximately $169,000 in licensee and royalty income compared to approximately $4.7 million in processing and storage fee revenue and approximately $169,000 in licensee and royalty income for the second quarter of fiscal 2014.  The increase in processing and storage fee revenue is primarily attributable to a 10% increase in recurring 

 

 

Read More


Request Investor Information

Send me press release announcements by email:
|<<1 2 3 4 5 6 7 8 9 10...>>|